U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
170821170821Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent MicroalbuminuriaCompletedNo Results AvailableType 2 Diabetes|MicroalbuminuriaDrug: irbesartanhttps://ClinicalTrials.gov/show/NCT00320879
170822170822Evaluation of Symptoms, Complications and Side Effects of Adding Medications Continuously To Subcutaneous Infusion (Hypodermoclysis) In Home Care Hospice PatientsCompletedNo Results AvailableHome Infusion Therapy|Infusion PumpsDevice: syringe driverhttps://ClinicalTrials.gov/show/NCT00320866
170823170823A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and SecretionCompletedNo Results AvailableDiabetes Mellitus, Non-Insulin-DependentDrug: Vitamin Dhttps://ClinicalTrials.gov/show/NCT00320853
170824170824Internal and Familial Resources and Motherhood. Follow Up of Mothers With Twins and Preterm Infants Versus Mothers With Single Full Term InfantsNot yet recruitingNo Results AvailableTwins|Preterm Infantshttps://ClinicalTrials.gov/show/NCT00320840
170825170825Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)CompletedNo Results AvailableMalignancies|LymphomaDrug: CS-1008 (humanized anti-DR5 antibody)https://ClinicalTrials.gov/show/NCT00320827
170826170826Phase 1 Study of VEGF Trap in Patients With Diabetic Macular EdemaCompletedNo Results AvailableDiabetic Macular EdemaDrug: VEGF Trap-Eyehttps://ClinicalTrials.gov/show/NCT00320814
170827170827Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.TerminatedHas ResultsOsteoarthritisDrug: Buprenorphine transdermal patch|Drug: Buprenorphine transdermal patchhttps://ClinicalTrials.gov/show/NCT00320801
170828170828Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)CompletedHas ResultsMacular DegenerationBiological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)|Biological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)|Biological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)|Biological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)|Biological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)https://ClinicalTrials.gov/show/NCT00320788
170829170829Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMDCompletedNo Results AvailableMacular DegenerationDrug: VEGF Traphttps://ClinicalTrials.gov/show/NCT00320775
170830170830Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing HospitalCompletedNo Results AvailableGlaucoma|PterygiumDevice: OculusGen Biodegradable Collagen Matrix Implanthttps://ClinicalTrials.gov/show/NCT00320762
170831170831Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas CancerCompletedNo Results AvailablePancreatic CancerDrug: Capecitabine|Drug: Docetaxel|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00320749
170832170832Galantamine for Cognition in People With SchizophreniaCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: galantaminehttps://ClinicalTrials.gov/show/NCT00320736
170833170833Nicotine Replacement Therapy for Smoking Cessation in SchizophreniaCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: bupropion, transdermal nicotine patchhttps://ClinicalTrials.gov/show/NCT00320723
170834170834Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast CancerCompletedHas ResultsBreast CancerDrug: Zoledronic acid|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00320710
170835170835Smoking Relapse Prevention in SchizophreniaCompletedNo Results AvailableSchizophrenia|Schizoaffective Disorder|SmokersDrug: bupropion|Drug: transdermal nicotine patch|Drug: short-acting nicotine replacement therapyhttps://ClinicalTrials.gov/show/NCT00320697
170836170836Serotonin Transporter Concentrations in Women With a History of Anorexia NervosaCompletedNo Results AvailableEating Disorders|Anorexia Nervosahttps://ClinicalTrials.gov/show/NCT00320684
170837170837Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode PsychosisActive, not recruitingNo Results AvailableSchizophreniaDrug: Aripiprazole|Drug: Risperidone|Drug: Clozapinehttps://ClinicalTrials.gov/show/NCT00320671
170838170838Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 AdjuvantCompletedNo Results AvailableMalariaBiological: MSP1 42-C1/Alhydrogel|Biological: CPG 7909https://ClinicalTrials.gov/show/NCT00320658
170839170839Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major DepressionCompletedNo Results AvailableDepressionDrug: Desipraminehttps://ClinicalTrials.gov/show/NCT00320632
170840170840Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine SurgeryCompletedNo Results AvailableScoliosis|Kyphosis|Lordosis|Spondylitis|Spinal StenosisDrug: Epsilon-Aminocaproic Acid (EACA)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00320619
170841170841Withdrawal of Immunosuppression in Pediatric Liver Transplant RecipientsActive, not recruitingHas ResultsLiver Transplant|ImmunosuppressionProcedure: Gradual withdrawal of immunosuppressive medicationhttps://ClinicalTrials.gov/show/NCT00320606
170842170842Correction of Myopia Evaluation Trial 2CompletedHas ResultsMyopiaDevice: Progressive Addition Lenses (PALs)|Device: Single Vision Lenses (SVLs)https://ClinicalTrials.gov/show/NCT00320593
170843170843An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional RegimenCompletedNo Results AvailableMetrorrhagiaDrug: norelgestromin/ethinyl estradiolhttps://ClinicalTrials.gov/show/NCT00320580
170844170844The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia NervosaCompletedNo Results AvailableOsteoporosisDrug: norgestimate/ethinyl estradiolhttps://ClinicalTrials.gov/show/NCT00320567
170845170845Motion Characteristics of the Foot and Ankle as Measured by Durometer ReadingsCompletedNo Results AvailableFoot Motion CharacteristicsBehavioral: Durometer analysishttps://ClinicalTrials.gov/show/NCT00320554
170846170846A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast CancerCompletedHas ResultsBreast CancerDrug: gemcitabine|Drug: paclitaxel|Drug: bevacizumabhttps://ClinicalTrials.gov/show/NCT00320541
170847170847Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedHas ResultsAttention Deficit Disorder With HyperactivityDrug: atomoxetinehttps://ClinicalTrials.gov/show/NCT00320528
170848170848Study of Pemetrexed Plus Cisplatin in Advanced Gastric CancerCompletedHas ResultsNeoplasm, GastricDrug: pemetrexed|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00320515
170849170849A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)CompletedNo Results AvailableAcute Coronary Syndrome|Type 2 DiabetesDrug: BXT-51072https://ClinicalTrials.gov/show/NCT00320502
170850170850Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With SchizophreniaCompletedHas ResultsSchizophreniaDrug: olanzapine|Drug: olanzapine pamoate depothttps://ClinicalTrials.gov/show/NCT00320489

* Görseller ve İçerik tekif hakkına sahip olabilir